Home » Topics » BioWorld Science, Dermatologic

BioWorld Science, Dermatologic
RSS

Krystal files IND with FDA for phase I/II study of KB-103 for dystrophic EB

March 28, 2018

Genentech develops anti-inflammatory nuclear receptor ROR-gamma inverse agonists

March 26, 2018

Bristol-Myers Squibb discovers new Toll-like receptor 7, 8 and 9 antagonists

March 26, 2018

Processa Pharmaceuticals assigned license for CTP-499

March 23, 2018

First patient dosed in phase II psoriasis trial of ABY-035

March 22, 2018

FDA approves Ilumya for moderate to severe plaque psoriasis

March 21, 2018

SNA-125 begins proof-of-concept trial in atopic dermatitis

March 13, 2018

European Commission approves Ameluz with daylight PDT

March 7, 2018

Phase III trials of olumacostat glasaretil for acne do not meet co-primary endpoints

March 6, 2018

AEC syndrome pathology linked to protein aggregation of the p63 transcription factor

March 6, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 16, 2026.
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
Keros reports beneficial effects of RKER-065 in ALS model
BioWorld Science
Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...